CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleLevered free cash flow is $25.61M, above the global median of $18.73M
- FinancialsAltman Z-Score 2.16: grey zone
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.18%
Annual Rate
CNY 0.01Paid unknown
Payout Ratio
14.7%Sustainable
Last Ex-Dividend
Jan 9, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
4.42BCNY659.88M · vs all stocks (USD)
Trailing P/E
79.00xRevenue (TTM)
1.73BCNY258.85M · vs all stocks (USD)
Profit Margin
3.04%Beta
0.7310xvs all stocks
52-Week Change
24.80%vs all stocks
Forward Annual Dividend Yield
0.18%vs all stocks
Market Capitalization
4.42BCNY659.88M · vs all stocks (USD)
Enterprise Value
5.12BCNY764.86M · vs all stocks (USD)
Trailing P/E
79.00xForward P/E
39.50xPrice to Sales (TTM)
2.55xPrice to Book (MRQ)
2.71xEnterprise to Revenue
2.96xEnterprise to EBITDA
30.85xGross Margin
21.21%Profit Margin
3.04%Operating Margin
3.89%Return on Assets (TTM)
2.03%Return on Equity (TTM)
3.39%Revenue (TTM)
1.73BCNY258.85M · vs all stocks (USD)
Revenue per Share (TTM)
3.14CNYUpdated Sep 21, 2026Quarterly Revenue Growth
-11.70%Gross Profit (TTM)
471.37MCNY70.39M · vs all stocks (USD)
EBITDA (TTM)
149.49MCNY22.32M · vs all stocks (USD)
Net Income (TTM)
52.68MCNY7.87M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-47.10%Operating Cash Flow (TTM)
98.82MCNY14.76M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
171.48MCNY25.61M · vs all stocks (USD)
Forward Annual Dividend Rate
0.0100CNYUpdated Sep 21, 2026Forward Annual Dividend Yield
0.18%vs all stocks
Trailing Annual Dividend Rate
0.0140CNYUpdated Sep 21, 2026Trailing Annual Dividend Yield
0.18%vs all stocks
Payout Ratio
14.69%Minority Interest (Equity)
58.19MCNYFY2025 · Dec 31, 2025Revenue
1.76BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
1.27BCNYFY2025 · Dec 31, 2025Gross Profit
492.23MCNYFY2025 · Dec 31, 2025Operating Income
162.83MCNY24.32M · vs all stocks (USD)
Pre-tax Income
77.51MCNYFY2025 · Dec 31, 2025Income Tax Expense
11.64MCNYFY2025 · Dec 31, 2025Net Income
65.87MCNYFY2025 · Dec 31, 2025EBIT
132.94MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
223.83MCNYFY2025 · Dec 31, 2025Research & Development
67.78MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
104.81MCNYFY2025 · Dec 31, 2025Other Operating Expenses
11.74MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
1.64MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
55.43MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.1085CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.1085CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
552.96MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
552.96MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
65.87MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
-5.87MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
-67.24MCNYFY2025 · Dec 31, 2025Free Cash Flow
-88.29MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
175.85MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
65.87MCNYFY2025 · Dec 31, 2025Other Non-cash Items
67.74MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-218.71MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
17.86MCNYFY2025 · Dec 31, 2025Capital Expenditures
-21.05MCNYFY2025 · Dec 31, 2025Net Acquisitions
88.81KCNYFY2025 · Dec 31, 2025Purchase of Investments
-147.75MCNYFY2025 · Dec 31, 2025Sale of Investments
168.88MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
160.84KCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
1.04BCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-1.24BCNYFY2025 · Dec 31, 2025Common Dividends Paid
-50.76MCNYFY2025 · Dec 31, 2025Other Financing Charges
236.92MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-15.37MCNYFY2025 · Dec 31, 2025Shares Outstanding
573.89MSharesUpdated Sep 21, 2026Float Shares
414.45MSharesUpdated Sep 21, 2026% Held by Insiders
29.88%vs all stocks
% Held by Institutions
1.50%vs all stocks
Total Cash (MRQ)
214.32MCNY32.00M · vs all stocks (USD)
Total Cash per Share (MRQ)
0.3880CNYUpdated Sep 21, 2026Total Debt (MRQ)
960.47MCNY143.43M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.5749xCurrent Ratio (MRQ)
1.26xBook Value per Share (MRQ)
2.92CNYUpdated Sep 21, 2026Total Assets
3.64BCNY543.79M · vs all stocks (USD)
Total Current Assets
2.14BCNYFY2025 · Dec 31, 2025Total Liabilities
1.98BCNYFY2025 · Dec 31, 2025Total Non-current Assets
1.50BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
105.36MCNYFY2025 · Dec 31, 2025Total Current Liabilities
1.87BCNYFY2025 · Dec 31, 2025Cash
178.59MCNYFY2025 · Dec 31, 2025Cash Equivalents
45.00MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
223.59MCNYFY2025 · Dec 31, 2025Other Short-term Investments
100.02MCNYFY2025 · Dec 31, 2025Accounts Receivable
990.55MCNYFY2025 · Dec 31, 2025Inventory
353.83MCNYFY2025 · Dec 31, 2025Accounts Payable
342.59MCNYFY2025 · Dec 31, 2025Short-term Debt
684.61MCNYFY2025 · Dec 31, 2025Other Current Liabilities
407.68MCNYFY2025 · Dec 31, 2025Long-term Debt
85.98MCNYFY2025 · Dec 31, 2025Common Stock (Book)
573.89MCNYFY2025 · Dec 31, 2025Retained Earnings
343.53MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
1.66BCNY248.27M · vs all stocks (USD)
Treasury Stock
109.80MCNYFY2025 · Dec 31, 202552-Week Low
6.13CNYUpdated Sep 21, 202652-Week High
9.44CNYUpdated Sep 21, 202652-Week Change
24.80%vs all stocks
Beta
0.7310xvs all stocks
50-Day MA
7.75CNYUpdated Sep 21, 2026200-Day MA
7.32CNYUpdated Sep 21, 2026Avg 10-Day Volume
16.06MSharesUpdated Sep 21, 2026Avg 30-Day Volume
22.53MSharesUpdated Sep 21, 2026Diluted EPS (TTM)
0.1000CNYUpdated Sep 21, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsWhere is this company structurally exposed?
Receivables Heavy and Growing
Money owed by customers keeps growing, and is much of its current assets.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 2.16: grey zoneSignificant
Altman Z-Score: 2.16
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Levered free cash flow is $25.61M, above the global median of $18.73MNotable
Levered free cash flow (USD): 25,607,395.114Global Median: 18,729,043.027
Companies that share the same coordination system — how they create, deliver, or capture value.
Nuvectis Pharma Inc.
Tier 1ProductionApproval-Gated PipelineRule
Jinhe Biotechnology Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Chengdu Shengnuo Biotech Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Jiangsu Lianhuan Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Shanghai Kinetic Medical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Senores Pharmaceuticals Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Climb Biotherapeutics, Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Zevra Therapeutics, Inc.
Tier 1ProductionApproval-Gated PipelineRule
Fuan Pharmaceutical Group Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Xiangxue Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Fischer Medical Ventures Ltd
1 interpretationReceivables Heavy and Growing
Cecep Environmental Protection Co. Ltd.
1 interpretationReceivables Heavy and Growing
Shanghai Yanpu Metal Products Co. Ltd.
1 interpretationReceivables Heavy and Growing